CF Capital’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
100,000
-123,714
-55% -$1.85M 1.64% 19
2025
Q4
$3.44M Sell
223,714
-61,286
-22% -$982K 1.71% 21
2025
Q3
$4.67M Sell
285,000
-202,619
-42% -$3.33M 2.87% 16
2025
Q2
$7.83M Sell
487,619
-212,381
-30% -$3.3M 9.99% 1
2025
Q1
$10.6M Buy
700,000
+243,600
+53% +$4.03M 10.83% 1
2024
Q4
$7.48M Buy
+456,400
New +$7.92M 8.06% 3

Other funds holding ECAT

CF Capital's ECAT Position: Q1 2026 in Review

CF Capital reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 55% in Q1 2026, selling an estimated $1.85M and leaving 100,000 shares worth $1.36M. The position accounts for 1.64% of the portfolio, ranked #19.

CF Capital first reported a position in ECAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.6M in Q1 2025. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.

  • CF Capital held 100,000 shares of BlackRock ESG Capital Allocation Term Trust worth $1.36M as of Q1 2026.
  • CF Capital sold 123,714 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $1.85M.
  • BlackRock ESG Capital Allocation Term Trust made up 1.64% of CF Capital's portfolio in Q1 2026, its #19 holding.
  • CF Capital first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2024 and has held it in 6 quarters since.
  • CF Capital's BlackRock ESG Capital Allocation Term Trust position peaked at $10.6M in Q1 2025.
  • 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.

Based on CF Capital's 13F filing for Q1 2026, filed 11 May 2026.